SILO

Silo Pharma, Inc.

Stock · NASDAQ

Program summary

FieldValueAs ofSource
Current authorization$1m30-Sep-2610-Q filed 13-Nov-26
Remaining authorization$927.5k30-Sep-2610-Q filed 13-Nov-26
Program expiry31-Dec-2630-Sep-2610-Q filed 13-Nov-26
Repurchased last quarter$72.5k30-Sep-2610-Q filed 13-Nov-26
Has used an ASRNo—

Programs

Authorized onAuthorizedRemainingExpiresTerms
20-Feb-26$1m$927.5k31-Dec-26Board of Directors authorized a stock repurchase plan to repurchase up to $1,000,000 of our issued and outstanding common stock, from time to time, with such program to be in place until December 31, 2026.10-Q filed 13-Nov-26

Open-market repurchases

Repurchased per month, USD (≈ shares × average price)
  1. Jul ’26
  2. Aug ’26
  3. ≈$34.6k
    Sep ’26
Month endedSharesAvg price≈ ValueSource
30-Sep-2616,873$2.05$34.6k10-Q filed 13-Nov-26
31-Aug-263,670$2.77$10.2k10-Q filed 13-Nov-26
31-Jul-266,015$4.61$27.7k10-Q filed 13-Nov-26
Filings through 30-Sep-26· checked 17-Nov-26